Dai-ichi Life Holdings’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-172,545
Closed -$6.93M – 162
2016
Q3
$6.93M Sell
172,545
-7,152
-4% -$269K 0.21% 98
2016
Q2
$5.97M Buy
179,697
+75,240
+72% +$2.57M 0.18% 121
2016
Q1
$3.07M Sell
104,457
-615
-0.6% -$17K 0.09% 230
2015
Q4
$2.77M Sell
105,072
-3,000
-3% -$77.9K 0.09% 236
2015
Q3
$2.56M Buy
108,072
+93,582
+646% +$2.26M 0.08% 258
2015
Q2
$344K Sell
14,490
-2,760
-16% -$62.3K 0.01% 471
2015
Q1
$410K Hold
17,250
– – 0.01% 465
2014
Q4
$366K Sell
17,250
-2,082
-11% -$41.8K 0.01% 468
2014
Q3
$329K Hold
19,332
– – 0.01% 489
2014
Q2
$277K Buy
19,332
+2,082
+12% +$28.2K 0.01% 533
2014
Q1
$213K Sell
17,250
-2,382
-12% -$27.5K 0.01% 575
2013
Q4
$215K Sell
19,632
-67,488
-77% -$761K 0.01% 580
2013
Q3
$1.01M Sell
87,120
-2,646
-3% -$31K 0.04% 392
2013
Q2
$1M Buy
+89,766
New +$1.06M 0.04% 380

Other funds holding EW

Dai-ichi Life Holdings's EW Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 172,545 shares — an estimated $6.93M sold.

Dai-ichi Life Holdings first reported a position in EW in Q2 2013 and held it in 14 quarters. The position peaked at $6.93M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 172,545 Edwards Lifesciences shares in Q4 2016, an estimated $6.93M.
  • Dai-ichi Life Holdings first reported a position in Edwards Lifesciences in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Edwards Lifesciences position peaked at $6.93M in Q3 2016.
  • 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.